Related Experiment Video

Updated: Jul 11, 2026

Assessing Replication and Beta Cell Function in Adenovirally-transduced Isolated Rodent Islets
09:31

Assessing Replication and Beta Cell Function in Adenovirally-transduced Isolated Rodent Islets

Published on: June 25, 2012

beta-cell function and anti-diabetic pharmacotherapy

Stefano Del Prato1, Cristina Bianchi, Piero Marchetti

  • 1Department of Endocrinology and Metabolism, Section of Diabetes and Metabolic Diseases, University of Pisa, Pisa, Italy. delprato@immr.med.unipi.it

Diabetes/Metabolism Research and Reviews
|September 22, 2007
PubMed

Insights

Type 2 diabetes involves progressive beta-cell loss. Maintaining tight metabolic control and reviewing therapeutic effects on beta-cell function are crucial for managing this chronic condition.

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Pharmacology

Background:

  • Type 2 diabetes is a chronic condition marked by declining glycemic control and progressive loss of pancreatic beta-cell mass and function.
  • Hyperglycemia and elevated free fatty acids create a toxic metabolic environment, accelerating beta-cell failure.
  • Effective management strategies are needed to preserve beta-cell function and prevent long-term diabetic complications.

Purpose of the Study:

  • To systematically review the impact of various antidiabetic agents on beta-cell function in type 2 diabetes.
  • To analyze the effects of sulfonylureas, incretin-mimetics, insulin sensitizers, alpha-glucosidase inhibitors, and insulin on beta-cell preservation.
  • To discuss emerging therapeutic approaches for maintaining beta-cell mass and function.

Main Methods:

  • Literature search to identify studies evaluating the effects of antidiabetic medications on beta-cell function.
  • Detailed analysis of the impact of different drug classes on beta-cell mass and function.
  • Review of current and future therapeutic strategies for beta-cell preservation.

Main Results:

  • Different classes of antidiabetic medications exhibit varying effects on beta-cell function.
  • Tight metabolic control is essential for preserving beta-cell function and preventing complications.
  • Specific agents may offer benefits in maintaining beta-cell mass and function, warranting further investigation.

Conclusions:

  • Therapeutic interventions play a significant role in modulating the progression of beta-cell dysfunction in type 2 diabetes.
  • Understanding the specific effects of each drug class is critical for optimizing treatment strategies.
  • Future research should focus on novel approaches to enhance beta-cell regeneration and survival.

More Related Videos

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model11:31

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

Methods to Assess Beta Cell Death Mediated by Cytotoxic T Lymphocytes12:12

Methods to Assess Beta Cell Death Mediated by Cytotoxic T Lymphocytes

Published on: June 16, 2011

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...